About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1/2

Use of a GLP-1R Agonist to Treat Opioid Use Disorder

NCT04199728•Milton S. Hershey Medical Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Opiate Substitution TreatmentOpioid-Related Disorders

Interventions

Liraglutide Pen Injector

Placebo

Locations

1

United States

Locations (1)

Penn State Milton S Hershey Medical Center

Hershey, Pennsylvania, United States

Key Dates

Start Date

October 18, 2021

Primary Completion Date

September 13, 2023

Completion Date

September 13, 2023

Last Updated

November 6, 2024

Related Studies

Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder

NCT03745339

Opioid-Related DisordersDrug Addiction

RECRUITINGPhase 2

Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder

NCT05336188

Opioid-Related DisordersMobile Applications+5 more

Active Not RecruitingEARLY Phase 1

Tau PET Imaging in Opioid Use Disorder

NCT05651516

Opioid-Related Disorders

Active Not RecruitingNA

Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing

NCT05505227

Opioid-Related DisordersBuprenorphine+2 more

Active Not RecruitingNA

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

NCT05657106

Opioid-Related DisordersHepatitis C (HCV)+6 more

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study

NCT03911466

Opioid-Related DisordersDrug Addiction+6 more

View all related studies

Sponsors

Lead Sponsor

Milton S. Hershey Medical Center

Collaborators

National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 6, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions